1 Min Read
May 9 (Reuters) - Mirna Therapeutics Inc:
* Mirna Therapeutics reports first quarter 2017 financial results
* Says net loss was approximately $5.0 million for three months ended March 31, 2017 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.